Oncotype DX

This is the beginning of a story. The gene set performed as a prognostic test well here. This needs to be confirmed but even more important is the need to demonstrate that it predicts, or does not predict, the benefit of radiation therapy for DCIS. This is the beginning of a story. The gene set performed as a prognostic test well here. This needs to be confirmed but even more important is the need to demonstrate that it predicts, or does not predict, the benefit of radiation therapy for DCIS.

Oncotype DX is a test designed for women with an early stage breast cancer, negative lymph nodes, and estrogen receptor positive breast cancer. The purpose of Oncotype DX is to determine whether seemingly low risk women, per their diagnosis, would benefit from chemotherapy.
If a person has a more advanced stage of breast cancer, positive lymph nodes, triple negative breast cancer, or another factor that would require chemotherapy then the oncologist does not order Oncotype DX because they already know the person requires chemotherapy.
So in your case I think you do not need the Oncotype DX because you are already having chemotherapy.
You may want to read more about Oncotype DX at the Genomics website...
http://www.genomichealth.com/en-US/OncotypeDX.aspx

Thanks,
Heather Oncotype DX is a test designed for women with an early stage breast cancer, negative lymph nodes, and estrogen receptor positive breast cancer. The purpose of Oncotype DX is to determine whether seemingly low risk women, per their diagnosis, would benefit from chemotherapy.
If a person has a more advanced stage of breast cancer, positive lymph nodes, triple negative breast cancer, or another factor that would require chemotherapy then the oncologist does not order Oncotype DX because they already know the person requires chemotherapy.
So in your case I think you do not need the Oncotype DX because you are already having chemotherapy.
You may want to read more about Oncotype DX at the Genomics website...
http://www.genomichealth.com/en-US/OncotypeDX.aspx

Thanks,
Heather